Lead sponsor

Shandong Suncadia Medicine Co., Ltd.

20 GLP-1 and incretin trials led. Source: ClinicalTrials.gov, as of July 1, 2026.

20

Trials led

6

Active

7,467

Total enrollment

17

Sites

Distinct sites across this sponsor's lead trials. A site running several of them counts once, matching the map. Total enrollment sums each trial's reported enrollment, whether planned or actual.

Portfolio

How this sponsor's trials break down

Trials by phase

Phase 1
8
Phase 1/2
1
Phase 2
6
Phase 3
5

Trials by status

Not yet recruiting
2
Recruiting
2
Active, not recruiting
2
Completed
12
Unknown
2

Trials led

RENEW-CKDeGFR ≥20Ph 3Not yet recruiting3,690
OUTSTAND-1HbA1c 7-10%Ph 3Completed284
SOLID-DKDBMI ≤40Ph 2Completed281